AlphaYou
Overview
Smart money at a glance
Filings to Sep 27, 2026Net selling: insiders sold $46.9M and bought $0 on the open market in 90 days (SEC Form 4). Congress: both buying and selling, $38K to $220K in total in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$46.9M netNet selling
- CongressSTOCK Act, last 180 days
- $38K to $220K tradedMixed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 11 added, 2 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- 10+ awardsAwards on record
Key stats
Fundamentals Sep 26- Open
- $100.81
- 52-wk high
- $132.39
- High
- $101.82
- 52-wk low
- $81.39
- Low
- $100.09
- Prev close
- $101.07
- Mkt cap
- $176.43B
- P/E
- 32.8x
- Volume
- 7.78M
- Fwd P/E
- 17.1x
- Beta
- 0.59
- Div yield
- 2.45%
- P/S
- 3.8x
- P/B
- 3.5x
- Profit margin
- +11.7%
- Op margin
- +14.7%
- ROE
- +10.6%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about ABT filings
Are insiders buying or selling Abbott Laboratories (ABT) stock?
Net selling: insiders sold $46.9M and bought $0 of ABT stock on the open market in the 90 days to Sep 27, 2026, according to SEC Form 4 filings. The largest was Ford, Robert B (Chairman And CEO), who sold $46.2M. The latest filing was on Sep 3, 2026.
Which members of Congress have traded ABT recently?
Rep. Richard Dean McCormick (R) sold $1K to $15K on Jul 30, 2026, disclosed 15 days later. Rep. Mike Kelly (R) sold $1K to $15K on Jul 17, 2026, disclosed 26 days later. Rep. Richard W. Allen (R) sold $15K to $50K on Jul 14, 2026, disclosed 35 days later. Rep. Rick Larsen (D) sold $1K to $15K on Jul 8, 2026, disclosed 4 days later. In total, 7 members disclosed 10 ABT trades with trade dates in the last 180 days, filed a median 27 days after trading.
How current is this ABT smart-money data?
This summary uses filings available on Sep 27, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders are trading both ways.
What funds are doing
Buys/Adds (2)
- CI
Citadel
$583.4M
added
- AQ
AQR
$219.5M
added
Sells/Trims (1)
- DS
D.E. Shaw
$409.8M
trimmed
What insiders are doing
Sells (3)
- MJ
Mccoy John A. Jr.
$3K
sold
- FR
Ford Robert B
$46.2M
sold
- ML
Morrone Louis H.
$643K
sold
What Congress is doing
How top traders are positioned
No tracked top-trader positions in ABT right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings came in 2.3% above what analysts expected.
Earnings per share
$1.28 expected
Revenue
No comparable estimate
Reports Oct 14, 2026, in 17 days
Estimates as of Sep 26, 2026
EPS expected
$1.41 to $1.44
Revenue expected
24 analysts
Last 30 days
Analysts cutting estimates
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $11.14B | $11.37B | $11.46B | $11.16B |
| Cost of what it sold | $4.85B | $5.03B | $4.92B | $4.88B |
| Gross profit | $6.29B | $6.34B | $6.54B | $6.28B |
| What it spent | ||||
| Research and development | $732.0M | $785.0M | $735.0M | $756.0M |
| Sales and admin | $3.09B | $3.05B | $3.13B | $3.74B |
| Other operating costs | $414.0M | $472.0M | $422.0M | -$55.0M |
| Total operating expenses | $4.24B | $4.31B | $4.29B | $4.44B |
| What was left | ||||
| Operating profit | $2.05B | $2.06B | $2.25B | $1.84B |
| Interest on debt | $121.0M | $44.0M | $120.0M | $174.0M |
| Profit before tax | $2.15B | $2.18B | $2.36B | $1.45B |
| Tax | $371.0M | $536.0M | $582.0M | $372.0M |
| Net profit | $1.78B | $1.64B | $1.78B | $1.08B |
| EBITDA | $3.05B | $3.09B | $2.82B | $2.25B |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is mixed
Tone of tracked coverage
3 Dividend Stocks To Watch As High Rates Test Defensive Shares
Leans bullishSep 26Form 4 Abbott Laboratories For: 25 September By Investing.com
NeutralSep 26At $103.99 a share, an Abbott Laboratories (ABT) director delivered or withheld shares for exercise costs or taxes.
NeutralSep 25STERIS stock last at USD 208.44, down 0.16 percent in New York trading
NeutralSep 25Stryker stock trades at USD 270.92, down 0.91 percent in New York trading
NeutralSep 25Abbott Laboratories stock falls 2.32 percent below yearly high effects? no
Leans bullishSep 25Abbott Laboratories stock loses 1.82 percent before the bell
Leans bearishSep 25How Lingo Partnership Will Impact Abbott Stock (ABT)
Leans bullishSep 25
Macro
30 macro signals shaping ABT right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results